| Matthew Silverman, MD | |
|
5925 15th Ave, Brooklyn, NY 11219-5009 | |
| (718) 972-2700 | |
| (718) 972-2701 |
| Full Name | Matthew Silverman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 42 Years |
| Location | 5925 15th Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003811522 | NPI | - | NPPES |
| 01084055 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 156406 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maimonides Medical Center | Brooklyn, NY | Hospital |
| Mount Sinai Beth Israel | New york, NY | Hospital |
| Entity Name | Boro Park Obstetrics & Gynecology P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467586792 PECOS PAC ID: 4789743576 Enrollment ID: O20081107000763 |
News Archive
Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
A new study published in the American Journal of Transplantation reveals that racial disparities exist in both the early and late steps in access to kidney transplantation. This study is part of the February special themed issue of the journal on racial disparity.
A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).
› Verified 7 days ago
| Entity Name | Womencare Obstetrics And Gynecology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336369859 PECOS PAC ID: 7214299239 Enrollment ID: O20180402001543 |
News Archive
Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
A new study published in the American Journal of Transplantation reveals that racial disparities exist in both the early and late steps in access to kidney transplantation. This study is part of the February special themed issue of the journal on racial disparity.
A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Silverman, MD 5925 15th Ave, Brooklyn, NY 11219-5009 Ph: (718) 972-2700 | Matthew Silverman, MD 5925 15th Ave, Brooklyn, NY 11219-5009 Ph: (718) 972-2700 |
News Archive
Intercell AG today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos' platform technology for monoclonal antibody discovery. The technology is based on expression cloning of monoclonal antibodies from human B-cells and enables the identification of anti-infective antibodies to prevent and treat infectious diseases.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
A new study published in the American Journal of Transplantation reveals that racial disparities exist in both the early and late steps in access to kidney transplantation. This study is part of the February special themed issue of the journal on racial disparity.
A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).
› Verified 7 days ago
Allix Megan Hillebrand, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219 Phone: 718-283-8000 | |
Viktoriya Bakcheva, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1599 West 6 Street, Brooklyn, NY 11204 Phone: 718-360-5014 Fax: 718-360-2314 | |
Mary Fatehi, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 97 Amity St Fl 3, Obgyn Associates At Lich, Brooklyn, NY 11201 Phone: 718-780-1231 Fax: 718-780-4987 | |
Dr. Bala Krishna Babji Ravi, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 374 Stockholm St, C/o Faculty Practice, Brooklyn, NY 11237 Phone: 718-963-6551 Fax: 718-963-6793 | |
Dr. Ling Zhu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 730 58th St, Brooklyn, NY 11220 Phone: 347-382-0338 | |
Dr. Nikolaos Kiouranakis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1012 Avenue Y, Brooklyn, NY 11235 Phone: 718-879-8877 Fax: 718-879-8866 |